ArticleThoracic cancer2021

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.